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INTRODUCTION
T rabeculectomy is the most commonly performed operation for intraocular pressure (IOP) reduction in glaucoma patients since 1968 [1] . Potentially devastating complications including early hypotony, choroidal detachment and bleb-related problems, however, have prompted calls for a safer, better surgical option [2] . In recent years, several alternative procedures have been evaluated relative to trabeculectomy [3] [4] . ExPress glaucoma filtration device (Alcon, Fort Worth, Texas, USA) implantation, for example, shows similar IOP-reduction efficacy with fewer complications [5] [6] .
The ExPress implant is a non-valved stainless steel tube that is inserted under a partial-thickness scleral flap to connect the anterior chamber to the subconjunctival space. The theoretical advantages of this device include increased reproducibility, simplicity, and reduced possibility of ocular tissue trauma.
Although glaucoma surgery has made significant progress in terms of safety, complications are still possible. One reportedly late postoperative complication of both trabeculectomy and implantation surgery is corneal decompensation [7] . Implantation surgery is considered to be a safer procedure overall, though it can cause more corneal complications than trabeculectomy [8] [9] . Corneal decompensation for instance, based on a long-term follow-up study of Ahmed valve implantation, has been reported to occur in up to 30% of patients [10] . There are as yet no long-term follow-up reports on the safety of ExPress implantation in the corneal endothelium. In the present study, therefore, we compared the clinical outcomes of ExPress implantation and standard trabeculectomy in patients with medically uncontrolled glaucoma, in terms of not only the hypotensive effect, but also any complications related to corneal endothelial damage. 
SUBJECTS AND METHODS

Surgical Procedures
All of the surgical procedures were performed, for consistency, by one experienced surgeon (Lee KW) using a standardized technique for each surgery type. In both procedures, a fornix-based conjunctiva flap was created with a relaxing incision on one side. Next, a 50% thickness limbus-based trapezoidal (3 mm×3 mm) scleral flap was constructed. In the ExPress group, after creation of the pilot hole using a 26 gauge needle, the filtration device (Ex-PRESS P 50) was implanted under the scleral flap; in the trabeculectomy group, sclerectomy was performed under the scleral flap, in the grey limbal zone, and a peripheral iridectomy was created. During both surgeries, the scleral wound bed was treated for 2min with 0.02% mitomycin C-soaked sponges. The scleral flap and conjunctiva were closed with 10/0 nylon sutures. Postoperatively, topical antibiotics and steroid treatment were administered. Statistical Analysis IBM SPSS Statistics ver. 21.0 software (SPSS, Chicago, IL, USA) was used for the statistical analysis. Data were obtained in the forms of mean±SD and frequency percentage. The inter-group analysis was performed by MannWhitney U test. For categorical data, the Chi-square and Fisher exact tests were used. Intra-group differences, obtained from data taken at different time points, were evaluated using the Wilcoxon signed-rank test. The success rates between the groups were compared by Kaplan-Meier life table analysis and log rank test. P values <0.05 were considered to be significant.
RESULTS
In total, 40 eyes of 40 participants were enrolled, 17 of which were subject to ExPress glaucoma filtration device implantation (ExPress) and 23 standard trabeculectomy (Trab). The demographic data are summarized in Table 1 . There were no significant differences in sex, mean age, visual acuity, glaucoma severity, IOP or number of antiglaucoma medications between the 2 groups. Intraocular Pressure Figure 1 shows the mean postoperative IOP in both groups. The mean preoperative IOP in the ExPress group was 27.1±10.1 mm Hg. After 12mo of follow up, it had decreased by 55.1%, to 12.1±4.2 mm Hg (P=0.01). ). There were no statistically significant inter-group differences in the number of medications at any time pre-or postoperatively (Table 3) . Surgical Success Kaplan-Meier survival curves of the ExPress and Trab groups are plotted in Figure 4 . Complete success was achieved in 65% and 61% of the patients, respectively (P=0.810), while qualified success was achieved in 82% and 78% of patients, respectively (P=0.757). [6, 11] . In the present study, the ExPress group relative to the Trab group had similar IOP-lowering and success rates but a lower rate of IOP fluctuation. Throughout the follow-up period, good IOP control was achieved in both groups. A trend toward lower mean IOP in the ExPress group was observed, though this did not represent a statistically significant difference relative to the Trab group. The number of antiglaucoma medications used postoperatively was not significantly different between the two groups.
Long-term Intraocular Pressure Fluctuation
Complications and Additional Procedures
Our results are in accordance with those of a prospective, case control study by Wagschal et al [11] . The rate of complete success was 70% after ExPress implantation compared with 57% after trabeculectomy at the 1y follow-up. There were no differences between the 2 groups in IOP, success rates, complications or additional intervention. Dahan et al [12] reported the results of a prospective comparison between ExPress implantation and trabeculectomy. As in the present study, both treatment groups demonstrated significant IOP decrease from the baseline: 44% for the ExPress group, and 48% for the trabeculectomy group. Unlike our result however, the eyes receiving ExPress implantation had a significantly higher probability of complete success. This might be partially explained by their lower, <18 mm Hg IOP cut-off point. The statistically significant IOP-fluctuation difference (to the advantage of the ExPress group) observed in the early postoperative period in our study is noteworthy. There have been no reports in the literature on the rate of IOP fluctuation in cases of ExPress implantation in glaucoma patients. The importance of IOP fluctuation nonetheless was identified in the pointwise linear regression analysis of AGIS patients reported by Nouri-Mahdavi et al [13] . Indeed, in their study, IOP fluctuation remained a significant predictor of VF worsening despite inclusion of mean IOP and number of glaucoma interventions as independent covariates in their regression models.
As for the present study, although good IOP control was achieved in both groups, IOP fluctuation was significantly lower after ExPress implantation in the early postoperative period from week 1 to month 3. In contrast to trabeculectomy, ExPress implantation does not require either sclerostomy or peripheral iridectomy. This might reduce the variability of results among ExPress implantation patients relative to trabeculectomy cases. This might also reduce postoperative inflammation, which is a very desirable effect [14] . One possible explanation for the present result is that the small lumen of the ExPress device provided additional resistance to aqueous flow during the early postoperative period. In fact, aqueous flow through that small lumen probably is more constant than that through the wide sclerectomy of trabeculectomy, even when both apertures are secured by overlying scleral flaps. During the immediate postoperative period, there was a greater need for postoperative manipulation (specifically, laser suturelysis) in the Trab group than in the ExPress group. The Trab group's higher rate of IOP fluctuation during the first week might be associated with this finding. In this study, trabeculectomy resulted in a higher rate of postoperative complications (39%) than ExPress implantation (17%). Most notably, hyphema and early hypotony were observed only in the Trab group. These results are in accordance with Dahan and Carmichael's [15] study, which reported a lower rate of postoperative complications in the ExPress group (20% vs 33%). These and other such results are the reason that ExPress implantation has been proposed and promoted as a less invasive procedure than trabeculectomy, given particularly its lower rate of complications resulting from postoperative hypotony.
The results of studies on the impact of trabeculectomy on ECD vary greatly: for example, from 1.6% to 54.8% in investigations conducted by Smith et al [16] . There have been no reports in the literature on the long-term effects of ExPress shunt on endothelial cells. In our analysis, the ECD loss % was significantly higher in the Trab group. The exact mechanics of endothelial damage by trabeculectomy are unknown. There are, however, hypotheses, that such damage is caused by a postoperative inflammatory reaction in the anterior chamber or by hypoxia directly or indirectly induced by persistent IOP elevation [7, 17] . As noted earlier in these pages, ExPress implantation, in the present study, induced a lower rate of postoperative IOP fluctuation. ExPress implantation, furthermore, does not require a large sclerectomy or an iridectomy, which can reduce operative time and, thus too, postoperative inflammation. These differences might also tend toward reduced postoperative endothelial cell loss in ExPress compared with Trab patients.
Another unfavorable factor with respect to postoperative endothelial damage is the use of antimetabolites and viscoelastics substances during surgery. Antimetabolites' corneal endothelial cytotoxicity has been demonstrated in previous studies [18] [19] .
Remnant viscoelastic material in the anterior chamber, meanwhile, can interfere with aqueous outflow, thereby inducing IOP spikes in the early postoperative period. Anterior chamber collapse during sclerostomy or peripheral iridectomy also can damage corneal endothelial cells.
The major limitations of our study are its small sample size 
